Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anticoagulant, complications of
anticoagulant, self-monitoring
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation clinic
artificial intelligence
atrial fibrillation
atrial fibrillation, risk stratification
cerebrovascular accident
cerebrovascular accident, prevention of
cerebrovascular accident, severity
CHADS-VaSC score
compliance
complications
computers, medicine and
controversies in neurology
coumarin
dabigatran
dabigatran, dose
efficacy
factor Xa inhibitor
HAS-BLED score
heart valve, prosthetic
hemorrhagic diathesis
INR value, time in range
INR values
intracerebral hemorrhage
laboratory values, normal
medical app
microhemorrhage, intracerebral
mortality
non-vitamin K antagonist oral anticoagulants
patient information and support
platelet inhibiting drugs
point of care
practice guidelines
prevention of neurologic disorders
quality of life
RELY trial
review article
safety
self monitoring
smartphone
treatment of neurologic disorder
Showing articles 550 to 600 of 1135 << Previous Next >>

Anticoagulants Versus Antiplatelet Agents for Acute Ischemic Stroke
Stroke 34:1571-1572, Berge,E. &Sandercock,P., 2003

Can Patients be Anticoagulated After Intracerebral Hemorrhage?
Stroke 34:1710-1716, Eckman,M.H.,et al, 2003

Cranial MR Imaging Findigns of Potassium Chlorate Intoxication
AJNR 24:1396-1398, MutluH.,et al, 2003

A Risk Score for Predicting Stroke or Death in Individuals with New-Onset Atrial Fibrillation in the Community
JAMA 290:1049-1056,1093, Wang,T.J.,et al, 2003

Stroke Prevention in Atrial Fibrillation
JAMA 290:1093-1095, Waldo,A.L., 2003

A Clinical Comparison of Non-Traumatic Acute Subdural Haematomas Either Related to Coagulopathy or of Arterial Origin Without Coagulopathy
Acta Neurochir 145:541-546, Depreitere, B.,et al, 2003

Clinical Profile of Stroke in 900 Patients with Hypertrophic Cardiomyopathy
J Am Coll Cardiol 39:301-307, Maron,B.J.,et al, 2002

Antiphospholipid Syndrome and Multiple Ischemic Strokes in a Patient with Myasthenia Gravis
Kurume Med J 49:211-216, Kaji, M.,et al, 2002

Emergent Use of Anticoagulation for Treatment of Patients with Ischemic Stroke
Stroke 33:856-861, Adams,H.P., 2002

Use of Intravenous Heparin by North American Neurologists
Stroke 33:1574-1577, Al-Sadat,A.,et al, 2002

Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002

Aspirin Should be First-Line Antiplatelet Therapy in the Secondary Prevention of Stroke
Stroke 33:2137-2139, Warlow,C., 2002

Leukoaraiosis is Associated with Warfarin-Related Hemorrhage Following Ischemic Stroke
Neurol 59:193-197, Smith,E.E.,et al, 2002

Intracerebral Hemorrhages Associated with Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab
Stroke 33:1916-1919, Qureshi,A.I.,et al, 2002

Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfarctionated Heparin for Acute Ischemic Stroke (Cochrane Review)
Stroke 33:1925-1926, Counsell,C. &Sandercock,P., 2002

Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke
Stroke 33:1927-1933, Moonis,M. &Fisher,M., 2002

Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002

Transoesophageal Echocardiography in Selecting Patients for Anticoagulation After Ischaemic Stroke or Transient Ischaemic Attack
JNNP 73:29-33, Strandberg,M.,et al, 2002

MR Changes after Acute Cyanide Intoxication
AJNR 23:1398-1401, Rachinger,J.,et al, 2002

Delayed Neuropathy and Myelopathy After Organophosphate Intoxication
NEJM 347:1119-1121, Chuang,C.,et al, 2002

New Evidence for Stroke Prevention
JAMA 288:1396-1398, Straus,S.E.,et al, 2002

New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002

Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002

Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002

A Blinding Combination
Lancet 360:1220, Matthews,B.N.,et al, 2002

Effect on Mood of Subthalamic DBS for Parkinson's Disease
Neurol 59:1427-1429, Berney,A.,et al, 2002

Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
JAMA 288:2441-2448, van Walraven,C.,et al, 2002

Transient Ischemic Attack
NEJM 347:1687-1692, Johnston,S.C., 2002

Chorea and Antiphospholipid Antibodies: Treatment with Methotrexate
Neurol 56:137-138, Paus,S.,et al, 2001

Immediate Anticoagulation in Acute Focal Brain Ischemia Revisited
Stroke 32:577-578,579, Chamorro,A., 2001

Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001

Suppression of Recurrent Transient Ischemic Attacks by a Statin Agent
Neurol 56:531-532, Alberts,M.J., 2001

Use of Specialized Coagulation Testing in the Evaluation of Patients with Acute Ischemic Stroke
Neurol 56:624-627, Bushnell,C.,et al, 2001

Warfarin Therapy for an Octogenarian who has Atrial Fibrillation
Ann Int Med 134:465-474, Gage,B.F.,et al, 2001

Spontaneous Dissection of the Carotid and Vertebral Arteries
NEJM 344:898-906, Schievink,W.I., 2001

Atrial Fibrillation
NEJM 344:1067-1078, Falk,R.H., 2001

Rescue Treatment with Abciximab in Acute Ischemic Stroke
Neurol 56:1585-1587, Lee,K.Y.,et al, 2001

A Language Barrier, Abdominal Pain, and Double Vision
Lancet 357:2022, Basnyat,B.,et al, 2001

Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
JAMA 286:78-82, Akkerhuis,K.M.,et al, 2001

Compliance With Secondary Prevention of Ischemic Stroke
Stroke 32:1884-1889, Sappok,T.,et al, 2001

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes Without St-Segment Elevation
NEJM 345:494-502, The Clopidogrel in Unstable Angina to Prevent Recu, 2001

Tinzaparin in Acute Ischaemic Stroke (TAIST):A Randomised Aspirin-Controlled Trial
Lancet 358:702-710,683, Bath,P.M.W.,et al, 2001

Risk Factors for Visual Loss in Giant Cell (Temporal) Arteritis:A Prospective Study of 174 Patients
Am J Med 111:211-217, Liozohn,E.,et al, 2001

Safety of Anticoagulation for Cerebral Venous Thrombosis Associated with Intracerebral Hematoma
Neurol 57:1138-1139, Fink,J.N.&McAuley,D.L., 2001

Nonrandomized Comparison of Local Urokinase Thrombolysis Versus Systemic Heparin Anticoagulation for Superior Sagittal Sinus Thrombosis
Stroke 32:2310-2317, Wassay,M.,et al, 2001

Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial
Stroke 32:2333-2337, Saxena,R.,et al, 2001

A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001

Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001

Combination Therapy With Clopidogrel and Aspirin
Stroke 32:2948-2949, Albers,G.W. &Amerenco,P., 2001

Acute Stroke Care in Non-urban Emergency Departments
Neurol 57:2006-2012, Burgin,W.S.,et al, 2001



Showing articles 550 to 600 of 1135 << Previous Next >>